CrossPointe Nouvel Espoir
Private foundation · Laval, Quebec · BN 777625211RR0001 · Christianity
Source: T3010 return, FPE 2024-12-31. Split of total expenditures ($121,936) as filed with the CRA.
CrossPointe Nouvel Espoir is a private foundation based in Laval, Quebec, classified by the CRA under christianity. In its fiscal year ending December 31, 2024, it reported $169K in revenue and $122K in expenditures.
Its funding that year was roughly 100% from donations.
Compared with 14,125 religious charities of similar size, its share of spending on mission — charitable programs plus grants to other charities — ranked above 13% of peers. Its fundraising cost per donated dollar was lower than 100% of that peer group.
Its filed list of directors and trustees shows 3 names.
In its own words
L'eglise se rassemblait chaque vendredi et dimanche pour des rencontres de priere et d'enseignement bibliques . L'eglise a organisé une retraite spirituelle pour tous ses membres . Nous avons organisé des sorties a l'extérieur pour annoncer la parole . Des ateliers pour aider les femmes monoparentales aider les nouveaux arrivants dans leur integration . Nous avons pu rendre visite aux nouveaux parents en apportant une trousse pour les bébés . L'eglise a fait des seances de conseil confidentielles aux membres .
Ongoing-program description from its T3010 filing, verbatim.
The ledger, 2024–2024
| Year | Revenue | Spending | Programs | Fundraising | Gifts out | Net assets |
|---|---|---|---|---|---|---|
| 2024 | $169K | $122K | $0 | $0 | $26K | -$3,110 |
Revenue printed in red where the year ran a deficit. Fiscal years by period end.
Directors & trustees (2024)
Nadia Nukuri (administrateur); Abiueyuwa Bless Julius Samuel (administrateur); Rosine Gahimbare (administrateur).
As listed on its 2024 return.
Check the source
Every figure on this page is from CrossPointe Nouvel Espoir’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 777625211RR0001), or read how we compute the receipt.